CIK: 0001799883 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value ($000): $264,408 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TRDA | ENTRADA THERAPEUTICS INC | 4,408,379 | $39,852 | 15.1% | $17.12 | — | COM | 29384C108 |
| ELVN | ENLIVEN THERAPEUTICS INC | 1,322,477 | $26,026 | 9.8% | $20.34 | +5.8% | COM | 29337E102 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,027,711 | $18,643 | 7.1% | $12.62 | +74.7% | COM | 252828108 |
| SKYE | SKYE BIOSCIENCE INC | 9,913,168 | $15,762 | 6.0% | $11.84 | -76.9% | COM NEW | 83086J200 |
| PHVS | PHARVARIS N V | 797,600 | $12,522 | 4.7% | $19.05 | -11.5% | COM | N69605108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 830,945 | $11,949 | 4.5% | $11.45 | — | SPONSORED ADS | 152309100 |
| CAMP | CAMP4 THERAPEUTICS CORP | 2,927,915 | $11,712 | 4.4% | $8.22 | -41.1% | COM | 13463J101 |
| BHVN | BIOHAVEN LTD | 478,972 | $11,514 | 4.4% | $33.89 | +4.1% | COM | G1110E107 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 282,313 | $11,030 | 4.2% | $25.81 | +66.9% | CLASS A ORD | 61559X104 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 736,595 | $9,929 | 3.8% | $17.93 | -5.0% | COM | 92790C104 |
| TECX | TECTONIC THERAPEUTIC INC | 511,660 | $9,061 | 3.4% | $15.77 | +106.6% | COM | 878972108 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 497,270 | $9,025 | 3.4% | $32.09 | -30.4% | COM NEW | 15117B202 |
| TYRA | TYRA BIOSCIENCES INC | 939,298 | $8,735 | 3.3% | $15.18 | -14.8% | COM | 90240B106 |
| ERAS | ERASCA INC | 5,405,404 | $7,405 | 2.8% | $2.16 | -20.5% | COM | 29479A108 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 2,353,304 | $7,060 | 2.7% | $11.59 | -53.4% | COM | 04317A107 |
| ANAB | ANAPTYSBIO INC | 357,733 | $6,650 | 2.5% | $28.24 | -40.9% | COM | 032724106 |
| PRAX | PRAXIS PRECISION MEDICINES I | 170,000 | $6,438 | 2.4% | $44.86 | +39.2% | COM NEW | 74006W207 |
| GHRS | GH RESEARCH PLC | 572,665 | $6,316 | 2.4% | $10.15 | +10.2% | ORDINARY SHARES | G3855L106 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 1,050,000 | $5,691 | 2.2% | $9.03 | -22.5% | COM NEW | 30233G209 |
| VKTX | VIKING THERAPEUTICS INC | 189,593 | $4,579 | 1.7% | $14.60 | +116.5% | COM | 92686J106 |
| — | VOR BIOPHARMA INC | 6,361,723 | $4,565 | 1.7% | $43.10 | — | COM | 929033108 |
| SRZN | SURROZEN INC | 310,000 | $3,615 | 1.4% | $11.62 | 0.0% | COM NEW | 86889P208 |
| TARA | PROTARA THERAPEUTICS INC | 800,000 | $3,408 | 1.3% | $3.23 | +38.3% | COM STK | 74365U107 |
| — | SCPHARMACEUTICALS INC | 1,200,647 | $3,158 | 1.2% | $5.92 | — | COM | 810648105 |
| — | RALLYBIO CORP | 3,630,724 | $2,376 | 0.9% | $17.58 | — | COM | 75120L100 |
| — | ADVERUM BIOTECHNOLOGIES INC | 541,666 | $2,367 | 0.9% | $14.14 | — | COM NEW | 00773U207 |
| SLN | SILENCE THERAPEUTICS PLC | 476,200 | $1,343 | 0.5% | $21.60 | — | ADS | 82686Q101 |
| ALEC | ALECTOR INC | 995,841 | $1,225 | 0.5% | $3.76 | -56.7% | COM | 014442107 |
| — | CIDARA THERAPEUTICS INC | 56,725 | $1,222 | 0.5% | $11.94 | — | COM NEW | 171757206 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 490,000 | $779 | 0.3% | $23.99 | -91.0% | COM | 98943L107 |
| — | MERSANA THERAPEUTICS INC | 1,305,000 | $449 | 0.2% | $4.03 | — | COM | 59045L106 |